Coverage by Oliver Longstaff for Pα+, edited by Josh Hardman. *** On Tuesday, Dr. Steffen Thirstrup, Chief Medical Officer (CMO) of the European Medicines Agency (EMA), gave a live presentation and Q&A on the topic of ‘psychedelics and their therapeutic use’. Hosted by Alessandro Faia, EMA Press Officer, this LinkedIn Live session discussed the EU regulatory system, its ability to respond…

Source

Previous articleThe Church of the Eagle and the Condor Settles with Federal Agencies, Can Continue Importing and Using Ayahuasca
Next articleAustralian Federal Government Funds Trial of MDMA-Assisted Therapy for Individuals Affected by Northern River Floods